Arrowhead Pharmaceuticals (ARWR) director sells 2,000 shares
Rhea-AI Filing Summary
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) director Adeoye Y. Olukotun reported a sale of 2,000 shares of common stock on 2026-08-18 in an open-market or private transaction at $86.96 per share. Following this transaction, he directly holds 31,600 shares, which the company notes include previously reported shares underlying Restricted Stock Units, some of which remain subject to vesting conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,000 shares
Net Sell
1 txn
Insider
OLUKOTUN ADEOYE Y
Role
Director
Sold
2,000 shs ($174K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 2,000 | $86.96 | $174K |
Holdings After Transaction:
Common Stock — 31,600 shares (Direct)
Footnotes (1)
- F1. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.
Key Figures
Shares sold: 2,000 shares of Common Stock
Sale price per share: $86.96 per share
Shares held after transaction: 31,600 shares
+1 more
4 metrics
Shares sold
2,000 shares of Common Stock
Sale on 2026-08-18 reported by director Adeoye Y. Olukotun
Sale price per share
$86.96 per share
Price for the 2,000 ARWR shares sold on 2026-08-18
Shares held after transaction
31,600 shares
Direct holdings following the reported sale, including RSU-related shares
Net shares sold
2,000 shares
Net-sell direction across all transactions in this Form 4
Key Terms
Restricted Stock Units, vesting conditions, open market or private transaction
3 terms
Restricted Stock Units financial
"Includes previously reported shares of common stock underlying Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vesting conditions financial
"a portion of which are still subject to certain vesting conditions"
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
open market or private transaction financial
"Sale in open market or private transaction"
FAQ
What insider transaction did ARWR disclose for Adeoye Y. Olukotun?
Adeoye Y. Olukotun reported a sale of 2,000 ARWR common shares on 2026-08-18 in an open-market or private transaction at $86.96 per share.
Was the August 18, 2026 ARWR insider trade a purchase or a sale?
The August 18, 2026 transaction reported by Adeoye Y. Olukotun in ARWR was a sale of 2,000 shares of common stock at $86.96 per share.
What role does Adeoye Y. Olukotun have at ARWR in this Form 4?
In this Form 4, Adeoye Y. Olukotun is identified as a director of ARROWHEAD PHARMACEUTICALS, INC. and not as an officer or ten percent owner.
Do Adeoye Y. Olukotun’s ARWR holdings include unvested equity?
Yes. The 31,600 shares reported after the transaction include shares of common stock underlying Restricted Stock Units, and a portion of those RSUs is still subject to vesting conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
